查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1616303

2024 - 2032 年医学样本追踪系统市场机会、成长驱动因素、产业趋势分析与预测

Medical Specimen Tracking Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球医学样本追踪系统市场价值为 10 亿美元，预计 2024 年至 2032 年复合年增长率为 11.2%。在医疗保健和实验室环境中，精确的标本处理可确保可靠的诊断结果和病人安全。标本的错误识别、遗失或污染可能导致错误诊断、延迟治疗和损害患者治疗结果，这凸显了强大的追踪系统的重要性。无线射频识别 (RFID) 和条码系统等技术改进显着增强了对样本移动和状态的即时监控。

例如，RFID 技术可以实现自动资料收集并减少手动输入错误，从而提高样本追踪的准确性和可靠性。医院和诊断实验室越来越多地采用这些系统来简化操作并最大限度地减少人为错误。例如，克利夫兰诊所使用 RFID 和条码实施了复杂的样本追踪系统，减少了贴错标籤的样本并缩短了测试结果的周转时间。软体领域在 2023 年创造了超过 5.675 亿美元的收入。

先进的软体系统提供即时追踪功能、与实验室资讯系统 (LIS) 的资料整合以及详细的报告功能，这对于确保样本处理的准确性和完整性至关重要。医疗保健领域对监管合规性和品质保证的重视刺激了对满足 FDA 和 CLIA 等监管机构制定的严格标准的复杂追踪软体的需求。 2023 年，病患检测领域的产业份额超过 5.832 亿美元。慢性病盛行率的上升、人口老化以及对常规和预防性护理的需求不断增长推动了这一激增，因此需要准确、高效的标本处理。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 10亿美元
预测值 28亿美元
复合年增长率 11.2%

例如，越来越多的糖尿病和癌症筛检需要强大的样本追踪系统，以确保及时、准确的诊断结果。约翰霍普金斯医院等医疗保健提供者已经实施了先进的追踪系统来管理大量病患标本，最大限度地减少错误并提高工作流程效率。对患者安全和诊断准确性的关注推动了患者检测领域的市场扩张。 2023年，北美医学样本追踪系统市占率为3.871亿美元。

先进的医疗基础设施、不断增长的自动化需求以及严格的监管要求推动了北美市场的发展。该地区对病人安全和实验室品质控制的重视推动了条码和 RFID 系统等先进追踪技术的采用。例如，梅奥诊所和约翰霍普金斯医院已经实施了先进的标本追踪系统，以最大限度地减少错误并提高工作流程效率。由于慢性病盛行率上升和人口老化，诊断检测量不断增加，进一步推动了市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 对准确、高效的样本追踪的需求不断增长
      • 实验室越来越多地采用自动化
      • 日益关注病患安全和监管合规性
      • 追踪科技的进步
    • 产业陷阱与挑战
      • 将追踪系统与现有工作流程整合的复杂性
      • 发展中地区的认知有限
  • 成长潜力分析
  • 监管环境
  • 启动场景
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 软体
  • 硬体
  • 耗材

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

  • 主要趋势
  • 条码
  • 射频识别
  • 全球定位系统
  • 其他技术

第 7 章：市场估计与预测：按样本类型，2021 - 2032 年

  • 主要趋势
  • 患者测试
  • 临床试验测试
  • 其他标本类型

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 病理实验室
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • BioIT Solutions
  • Cryoport Systems, LLC
  • GAO Group
  • LabConnect
  • Laboratory Corporation of America Holdings.
  • LabWare
  • NovoPath
  • Quick International Courier
  • RMS Omega
  • STARLIMS Corporation
  • STORQ
  • Taylor Data Systems, Inc.
简介目录
Product Code: 11209

The Global Medical Specimen Tracking Systems Market was valued at USD 1 billion in 2023 and is projected to grow at a CAGR of 11.2% between 2024 and 2032. An increasing need for accurate and efficient specimen tracking drives this market. In healthcare and laboratory environments, precise specimen handling ensures reliable diagnostic results and patient safety. Misidentification, loss, or contamination of specimens can lead to incorrect diagnoses, delayed treatments, and compromised patient outcomes, underscoring the importance of robust tracking systems. Technological improvements, such as Radio Frequency Identification (RFID) and barcode systems, have significantly enhanced real-time monitoring of specimen movement and status.

RFID technology, for instance, allows automated data capture and reduces manual entry errors, improving the accuracy and reliability of specimen tracking. Hospitals and diagnostic laboratories are increasingly adopting these systems to streamline operations and minimize human error. Cleveland Clinic, for example, implemented a sophisticated specimen tracking system using RFID and barcodes, which has reduced mislabeled specimens and improved test result turnaround times. The software segment generated more than USD 567.5 million in 2023. The adoption of automation in laboratories and healthcare facilities is a major driver, as software solutions streamline specimen tracking processes, reduce human error, and enhance workflow efficiency.

Advanced software systems offer real-time tracking capabilities, data integration with laboratory information systems (LIS), and detailed reporting features, which are crucial for ensuring the accuracy and integrity of specimen handling. The emphasis on regulatory compliance and quality assurance in healthcare has fueled demand for sophisticated tracking software that meets stringent standards set by regulatory bodies like the FDA and CLIA. The industry share from the patient testing segment was over USD 583.2 million in 2023. This segment dominates the market due to the increasing volume of diagnostic tests performed in hospitals, clinics, and laboratories. The rising prevalence of chronic diseases, aging populations, and the growing demand for routine and preventive care drive this surge, necessitating accurate and efficient specimen handling.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1 Billion
Forecast Value$2.8 Billion
CAGR11.2%

For instance, the increasing number of diabetes and cancer screenings requires robust specimen tracking systems to ensure timely and precise diagnostic outcomes. Healthcare providers, such as Johns Hopkins Hospital, have implemented advanced tracking systems to manage the high volume of patient specimens, minimizing errors and enhancing workflow efficiency. This focus on patient safety and diagnostic accuracy drives the expansion of the patient testing segment in the market. In 2023, the North America medical specimen tracking systems market share accounted for USD 387.1 million in.

Advanced healthcare infrastructure, increasing demand for automation, and stringent regulatory requirements drive the North American market. The region's emphasis on patient safety and quality control in laboratories propels the adoption of sophisticated tracking technologies such as barcodes and RFID systems. For example, the Mayo Clinic and Johns Hopkins Hospital have implemented advanced specimen tracking systems to minimize errors and enhance workflow efficiency. The growing volume of diagnostic testing due to the rising prevalence of chronic diseases and the aging population further fuels market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for accurate and efficient specimen tracking
      • 3.2.1.2 Growing adoption of automation in laboratories
      • 3.2.1.3 Rising focus on patient safety and regulatory compliance
      • 3.2.1.4 Advancements in tracking technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Complexity in integrating tracking systems with existing workflow
      • 3.2.2.2 Limited awareness in developing regions
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Start-up scenarios
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major key players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Software
  • 5.3 Hardware
  • 5.4 Consumables

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Barcode
  • 6.3 RFID
  • 6.4 GPS
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Specimen Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Patient testing
  • 7.3 Clinical trial testing
  • 7.4 Other specimen types

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Pathology labs
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 BioIT Solutions
  • 10.2 Cryoport Systems, LLC
  • 10.3 GAO Group
  • 10.4 LabConnect
  • 10.5 Laboratory Corporation of America Holdings.
  • 10.6 LabWare
  • 10.7 NovoPath
  • 10.8 Quick International Courier
  • 10.9 RMS Omega
  • 10.10 STARLIMS Corporation
  • 10.11 STORQ
  • 10.12 Taylor Data Systems, Inc.